Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides

被引:69
作者
Dutertre, Sebastien [1 ]
Croker, Daniel [2 ]
Daly, Norelle L. [1 ]
Andersson, Asa [2 ]
Muttenthaler, Markus [1 ]
Lumsden, Natalie G. [1 ]
Craik, David J. [1 ]
Alewood, Paul F. [1 ]
Guillon, Gilles [3 ,4 ,5 ,6 ]
Lewis, Richard J. [1 ]
机构
[1] Univ Queensland, Inst Mol Biol, Brisbane, Qld 4072, Australia
[2] Xenome Ltd, Brisbane, Qld 4072, Australia
[3] CNRS, UMR 5203, F-34094 Montpellier, France
[4] Inst Genom Fonctionnelle, Dept Endocrinol, F-34094 Montpellier, France
[5] INSERM, U 661, F-34094 Montpellier, France
[6] Univ Montpellier, F-34094 Montpellier, France
关键词
D O I
10.1074/jbc.M706477200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the discovery of conopressin-T, a novel bioactive peptide isolated from Conus tulipa venom. Conopressin-T belongs to the vasopressin- like peptide family and displays high sequence homology to the mammalian hormone oxytocin ( OT) and to vasotocin, the endogenous vasopressin analogue found in teleost fish, the cone snail's prey. Conopressin-T was found to act as a selective antagonist at the human V-1a receptor. All peptides in this family contain two conserved amino acids within the exocyclic tripeptide ( Pro(7) and Gly(9)), which are replaced with Leu(7) and Val(9) in conopressin-T. Whereas conopressin-T binds only to OT and V-1a receptors, an L7P analogue had increased affinity for the V-1a receptor and weak V-2 receptor binding. Surprisingly, replacing Gly(9) with Val(9) in OT and vasopressin revealed that this position can function as an agonist/ antagonist switch at the V-1a receptor. NMR structures of both conopressin-T and L7P analogue revealed a marked difference in the orientation of the exocyclic tripeptide that may serve as templates for the design of novel ligands with enhanced affinity for the V-1a receptor.
引用
收藏
页码:7100 / 7108
页数:9
相关论文
共 39 条
[1]   A GOLDFISH MODEL FOR EVALUATION OF THE NEUROTOXICITY OF OMEGA-CONOTOXIN GVI-A AND SCREENING OF MONOCLONAL-ANTIBODIES [J].
ADEYEMO, OM ;
SHAPIRA, S ;
TOMBACCINI, D ;
POLLARD, HB ;
FEUERSTEIN, G ;
SIREN, AL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (03) :489-496
[2]   Arginine vasotocin a key hormone in fish physiology and behaviour: A review with insights from mammalian models [J].
Balment, RJ ;
Lu, W ;
Weybourne, E ;
Warne, JM .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2006, 147 (01) :9-16
[3]   Structural bases of vasopressin/oxytocin receptor function [J].
Barberis, C ;
Mouillac, B ;
Durroux, T .
JOURNAL OF ENDOCRINOLOGY, 1998, 156 (02) :223-229
[4]   Vasopressin receptors [J].
Birnbaumer, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (10) :406-410
[5]   New applications of simulated annealing in X-ray crystallography and solution NMR [J].
Brunger, AT ;
Adams, PD ;
Rice, LM .
STRUCTURE, 1997, 5 (03) :325-336
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin [J].
Chini, B ;
Mouillac, B ;
Balestre, MN ;
TrumppKallmeyer, S ;
Hoflack, J ;
Hibert, M ;
Andriolo, M ;
Pupier, S ;
Jard, S ;
Barberis, C .
FEBS LETTERS, 1996, 397 (2-3) :201-206
[8]  
CRUZ LJ, 1987, J BIOL CHEM, V262, P15821
[9]   Structures of μO-conotoxins from Conus marmoreus -: Inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons [J].
Daly, NL ;
Ekberg, JA ;
Thomas, L ;
Adams, DJ ;
Lewis, RJ ;
Craik, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25774-25782
[10]   [1-deamino-4-cyclohexylalanine] arginine vasopressin:: A potent and specific agonist for vasopressin V1b receptors [J].
Derick, S ;
Cheng, LL ;
Voirol, MJ ;
Stoev, S ;
Giacomini, M ;
Wo, NC ;
Szeto, HH ;
Mimoun, MB ;
Andres, M ;
Gaillard, RC ;
Guillon, G ;
Manning, M .
ENDOCRINOLOGY, 2002, 143 (12) :4655-4664